Endometriosis Trial, Recruiting NCT04704115 Sponsor: University Hospital, Lille Condition: Endometriosis
Back to Endometriosis

Endometriosis Trial, Recruiting

NCT04704115
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have an ovarian cyst (endometrioma) that is 6cm or larger, confirmed by MRI or ultrasound
  • You have endometriosis that may be limited to the ovaries, or may also affect other areas such as the lining of the pelvis or deeper tissues, or the wall of the uterus
  • Your cyst(s) can be on one or both ovaries

Who may not be able to join:

  • Your cyst shows unusual or abnormal features on scans or during keyhole surgery that may suggest something other than a typical endometrioma
  • You are currently pregnant
  • You have a medical reason why you cannot take a specific hormone-suppressing medication (GnRH agonist) used in this trial (confirm with trial site)
  • You have a medical reason why you cannot have keyhole surgery (laparoscopy)
  • You have a medical reason why you cannot have general anaesthesia
  • You do not wish to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Chrytèle RUBOD, MD,PhD, University Hospital, Lille

Phone: 0320445962

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
21 January 2021
Est. completion
1 December 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Rate of Recurrence of cyst ≥ 3 cm determined by MRI or pelvic ultrasonography (US)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov